Awardee OrganizationVIRGINIA COMMONWEALTH UNIVERSITY
Description
Abstract Text
Recent advances in the neurosciences, in seizure classification procedures
and in genetic methodologies have provided important new tools for
elucidating the importance of genetic, maternal and environmental factors
in risk for epilepsy. While it has been possible to conclusively
demonstrate that genetic factors influence seizure susceptibility in three
forms of epilepsy (benign neonatal, juvenile myoclonic and progressive
myoclonus), the contribution of genotype to seizure risk for most forms of
epilepsy is unknown. Objectives of the proposed study are to identify and
resolve the roles of genetic, maternal and environmental factors in the
etiology of seizures and specific epileptic syndromes and to examine the
role of the epilepsy phenotype in risk for congenital malformations among
offspring of seizure-affected individuals utilizing data on seizure
history and history of congenital malformations among the offspring of
twin pairs included in the population-based Virginia Twin Registry and
Norwegian Twin Panel. These registries, developed from vital records,
currently contain information on over 21 ,000 adult twin pairs and their
families. The proposed study will focus on the over 800 adult twin pairs
reporting seizures in one or both pair members, the estimated 350 young
twins to be identified by surveying their parents, the over 800 twin
kindreds reporting seizures in one or more offspring of twins but not in
the twins themselves and a group of age, sex, race, and zygosity matched
controls. Data pertinent to the occurrence of seizures in controls and to
the occurrence and type of seizures occurring in affected individuals will
be collected for analysis. Detailed information on reproductive history in
affected twin pairs, including that on congenital malformations in
offspring will also be collected. Cases will be coded for family
membership and validated using medical records. Coded cases will be
classified for seizure/epilepsy type using the International
Classifications of Seizures and of Epilepsy and Epileptic Syndromes. The
unique family structure of the data set to be collected will permit the
use of several different methodological approaches in evaluating the
hypotheses put forth in this study. Standard epidemiologic methods will be
used to examine the role of specific demographic factors on seizure
occurrence. The importance of genetic and maternal factors in determining
risk for epilepsy and specific epileptic syndromes and the role of the
epilepsy phenotype in risk for congenital malformations in offspring will
be assessed using classical twin and cotwin control studies. Logistic
regression techniques will be used in more detailed analyses of the
importance of genetic, maternal and environmental factors on seizure risk.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
105300446
UEI
MLQFL4JSSAA9
Project Start Date
01-May-1994
Project End Date
31-January-1999
Budget Start Date
01-April-1995
Budget End Date
31-January-1996
Project Funding Information for 1995
Total Funding
$586,101
Direct Costs
$482,462
Indirect Costs
$103,639
Year
Funding IC
FY Total Cost by IC
1995
National Institute of Neurological Disorders and Stroke
$586,101
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS031564-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS031564-02
Patents
No Patents information available for 5R01NS031564-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS031564-02
Clinical Studies
No Clinical Studies information available for 5R01NS031564-02
News and More
Related News Releases
No news release information available for 5R01NS031564-02
History
No Historical information available for 5R01NS031564-02
Similar Projects
No Similar Projects information available for 5R01NS031564-02